MEDI-8111

N/A

Report date: 2022/03/04 17:08:55

Base Information

Drug NameMEDI-8111
Drug Alias NamerhFIIMEDI-8111Rh-Factor-II
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionProthrombin replacementsBlood coagulation pathway activationFibrinogen metabolizers
TargetsFibrinogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc
Inactive CompaniesAstrazeneca Plc
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A